Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-05-15

Clinical Trial Update: Vibrotactile Coordinated Reset for the Treatment of Chronic Stroke [NA]

View source ↗

Summary

Stanford University is sponsoring a clinical trial evaluating vibrotactile coordinated reset therapy for stroke, currently not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Stanford University | Conditions: Chronic Stroke | NA | Status: NOT_YET_RECRUITING